本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Unicycive Therapeutics, Inc.

5.46
+0.12002.25%
成交量:26.76萬
成交額:145.88萬
市值:1.52億
市盈率:-3.50
高:5.52
開:5.40
低:5.32
收:5.34
52周最高:8.74
52周最低:3.71
股本:2,785.53萬
流通股本:2,722.58萬
量比:0.45
換手率:0.98%
股息:- -
股息率:- -
每股收益(TTM):-1.5585
每股收益(LYR):-1.6715
淨資產收益率:-101.07%
總資產收益率:-40.59%
市淨率:2.86
市盈率(LYR):-3.27

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

重要事件披露

Form 8-K - Current report
2026/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/08

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/02

重要事件披露

Form 8-K - Current report
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

重要事件披露

Form 8-K - Current report
2026/06/05

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

重要事件披露

Form 8-K - Current report
2026/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/04/06

重要事件披露

Form 8-K - Current report
2026/03/30

重要事件披露

Form 8-K - Current report
2026/03/30

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/11/14

重要事件披露

Form 8-K - Current report
2025/11/12

重要事件披露

Form 8-K - Current report
2025/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]